Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08YWE
|
||||
Former ID |
DNC006421
|
||||
Drug Name |
Pim[-Trp-Arg-Nva-Arg-Tyr-NH2]2
|
||||
Indication | Discovery agent | Investigative | [528136] | ||
Structure |
Download2D MOL |
||||
Formula |
C81H120N28O14
|
||||
Canonical SMILES |
CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)<br />NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(C<br />CCC(C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCCN=C(N)N)C(=O)<br />NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)<br />N)N)N
|
||||
InChI |
1S/C81H120N28O14/c1-3-14-56(70(116)102-60(24-12-36-96-80(90)91)74(120)106-62(66(84)112)38-44-26-30-48(110)31-27-44)100-72(118)58(22-10-34-94-78(86)87)104-76(122)64(40-46-42-98-54-20-7-5-16-50(46)54)108-68(114)52(82)18-9-19-53(83)69(115)109-65(41-47-43-99-55-21-8-6-17-51(47)55)77(123)105-59(23-11-35-95-79(88)89)73(119)101-57(15-4-2)71(117)103-61(25-13-37-97-81(92)93)75(121)107-63(67(85)113)39-45-28-32-49(111)33-29-45/h5-8,16-17,20-21,26-33,42-43,52-53,56-65,98-99,110-111H,3-4,9-15,18-19,22-25,34-41,82-83H2,1-2H3,(H2,84,112)(H2,85,113)(H,100,118)(H,101,119)(H,102,116)(H,103,117)(H,104,122)(H,105,123)(H,106,120)(H,107,121)(H,108,114)(H,109,115)(H4,86,87,94)(H4,88,89,95)(H4,90,91,96)(H4,92,93,97)/t52?,53?,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-/m0/s1
|
||||
InChIKey |
LTYROZHCAWVGIV-CTAKNGSMSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor type 1 | Target Info | Inhibitor | [528136] | |
Neuropeptide Y receptor type 4 | Target Info | Inhibitor | [528136] | ||
Neuropeptide Y receptor type 2 | Target Info | Inhibitor | [528136] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.